KYIV, Jan 20 – The Synevo laboratory, part of the Swedish holding Medicover, has launched PCR tests that detect British and South African coronavirus (COVID-19) strains, including their currently known mutations.

According to Synevo's press release, new PCR tests are carried out on new generation equipment and reagents from the U.S. company Abbott.

Investments in equipment for testing (two analyzers) amounted to more than EUR 200,000.